Crescent Biopharma Inc.
CBIO | NASDAQ
$12.95
-$0.53 (-3.93%)
Nov 2, 2026, 1:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -24.84M | -23.28M | -92.4M | -24.61M | -21.79M | -15.15M | -7.22M | -9.82M | -10.1M | -10.74M | -9.08M | -9.2M | -8.26M | -10.36M | -10.24M | -8.52M | -13.27M | -14.65M | -17.42M | -17.33M | -14.4M | -14.27M |
Depreciation & Amortization | 66K | 64K | 54K | 28K | 2K | n/a | n/a | 8.13K | 12.42K | 14.62K | 23.3K | 42.75K | 43.42K | 43.84K | 45.72K | 47.35K | 54.77K | 59.31K | 61.64K | 67.38K | 67.49K | 68.09K |
Stock-Based Compensation | 3.97M | 4.11M | 4.75M | 1.99M | 5.34M | 1.23M | 1.16M | 1.14M | 1.25M | 1.23M | 944.37K | 887.84K | 858.09K | 870.18K | 899.2K | 913.98K | 963.76K | 1.08M | 1.32M | 1.59M | 1.56M | 1.61M |
Other Working Capital | 1.52M | -5.62M | -20.26M | 3.47M | -1.21M | 2.55M | 2.64M | 551.81K | -426.37K | -1.07M | -238.36K | -726.85K | 398.77K | -1.89M | 1.06M | -844.46K | -3.18M | -552.42K | 2.32M | -1.68M | -60.54K | -1.77M |
Other Non-Cash Items | -1.67M | 97K | 80.1M | 94K | 2.21M | 2K | -30K | 500.86K | 174.05K | 169.57K | 196.11K | 227.19K | 222.45K | 219.12K | 213.85K | 208.68K | 207.16K | 198.81K | 194.08K | 189.44K | 184.94K | 182.76K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.01M | 10.07M | -19.24M | 4.96M | -2.16M | 3.07M | 2.39M | 182.84K | -231.14K | -1.18M | 299.87K | -638.45K | 160.11K | -2.38M | 1.17M | -1.26M | -4.19M | -383.87K | 3.04M | -1.46M | -1.03M | -1.72M |
Operating Cash Flow | -19.46M | -8.94M | -26.74M | -17.54M | -16.4M | -10.85M | -3.7M | -7.99M | -8.89M | -10.51M | -7.61M | -8.68M | -6.97M | -11.61M | -7.91M | -8.62M | -16.23M | -13.7M | -12.81M | -16.95M | -13.61M | -14.13M |
Capital Expenditures | -13K | -8.15M | -72.19M | -586K | -140K | n/a | n/a | -2 | -2.53K | -7.44K | -801 | -7.87K | -10.53K | -2.2K | -1 | -2.48K | -41.19K | -40.52K | -2.45K | -4.33K | -5.1K | -3.06K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.77M | -8M | -72M | n/a | n/a | n/a | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 1.76M | -8.15M | -72.19M | -586K | -140K | n/a | 30K | n/a | -2.53K | -7.44K | -801 | -7.87K | -10.53K | -2.2K | -1 | -2.48K | -41.19K | -40.52K | -2.45K | -4.33K | -5.1K | -3.06K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -144K | -6.95M | -177K | 177K | 146.86M | -1.49M | n/a | n/a | 500 | 4.9K | 999 | 61.62K | 20.11K | 33.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.24K |
Financial Cash Flow | 136K | -6.95M | 178.86M | -1.25M | 146.86M | -1.49M | n/a | n/a | 500 | 4.9K | 999 | 61.62K | 20.11K | 28.74M | 4.16M | n/a | n/a | n/a | 1.14M | 20.79K | n/a | 9.56M |
Net Cash Flow | -17.57M | -24.03M | 79.93M | -19.38M | 130.32M | -12.34M | -3.67M | -7.99M | -8.9M | -10.51M | -7.61M | -8.63M | -6.97M | 17.13M | -3.75M | -8.62M | -16.27M | -13.74M | -11.67M | -16.93M | -13.62M | -4.56M |
Free Cash Flow | -19.48M | -17.08M | -98.93M | -18.13M | -16.54M | -10.85M | -3.7M | -7.99M | -8.9M | -10.52M | -7.62M | -8.69M | -6.99M | -11.61M | -7.91M | -8.62M | -16.27M | -13.74M | -12.81M | -16.95M | -13.62M | -14.13M |
Adj. Free Cash Flow | -23.44M | -21.2M | -103.68M | -20.11M | -21.88M | -12.08M | -4.86M | -9.13M | -10.14M | -11.74M | -8.56M | -9.58M | -7.84M | -12.48M | -8.81M | -9.53M | -17.24M | -14.82M | -14.13M | -18.54M | -15.18M | -15.74M |
Maintenance CapEx | -13K | -64K | -66.08M | -586K | -140K | n/a | n/a | -2 | -2.53K | -7.44K | n/a | -7.87K | -10.53K | -2.2K | -1 | -2.48K | n/a | -40.52K | -2.45K | -4.33K | -5.05K | -3.06K |
Growth CapEx | n/a | -8.08M | -6.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -801 | n/a | n/a | n/a | n/a | n/a | -41.19K | n/a | n/a | n/a | -56 | n/a |
Owner Earnings | -19.48M | -9M | -92.82M | -18.13M | -16.54M | -10.85M | -3.7M | -7.99M | -8.9M | -10.52M | -7.61M | -8.69M | -6.99M | -11.61M | -7.91M | -8.62M | -16.23M | -13.74M | -12.81M | -16.95M | -13.62M | -14.13M |
Add to Watchlist
Select watchlists to add or remove CBIO